Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$18.10
-0.60-3.21%
Last update: Aug 7, 2:50 PM
Avalo Therapeutics Inc
AVTXNASDAQ
Earnings: Q2 2026 Earnings were released on Thu Aug 6th, before the market open
Avalo Therapeutics Market Sentiment
Market sentiment signals for Avalo Therapeutics (AVTX): analyst consensus, short interest, options flow and insider activity.
Key Signals
Analyst Consensus▲ Buy
Short Interest▼ 24.0% short float
Options Flow▲ 0.00 P/C ratio
Insider Activity— Neutral (30d)
Analyst Consensus
Buy
18 analysts
Options Flow (P/C)
0.00
More calls — Bullish
3 calls · 0 puts
Avg Consensus PT
$40
+119.6%
Highest Price Target
$60
+231.5%
Piper Sandler
Lowest Price Target
$15
-17.1%
HC Wainwright & Co.
Short Interest
24.0%
Rising — Bearish
Insider Activity (30d)
Neutral
Short Interest — % of Float
Recent Analyst Actions
| Date | Firm | Analyst & Accuracy | Upside / Downside | PT Change | Action | Rating |
|---|---|---|---|---|---|---|
| Aug 7, 2026 | Guggenheim | Yatin Suneja— | +165.2% | $50 → $48 | Maintained | Buy |
| Aug 7, 2026 | HC Wainwright & Co. | Mitchell S. Kapoor— | +65.7% | $35 → $30 | Maintained | Buy |
